Angel Hernandez
Salamanca, CL 37007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia.
Journal: Biomarker research
Published: September 19, 2024
NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival.
Journal: Free radical biology & medicine
Published: July 26, 2023
NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia.
Journal: Free radical biology & medicine
Published: December 19, 2022
Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia.
Journal: Leukemia
Published: March 21, 2022
Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison.
Journal: Frontiers in immunology
Published: March 04, 2022
A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival.
Journal: American journal of hematology
Published: December 30, 2021
Granuloma Formation in a Cyba-Deficient Model of Chronic Granulomatous Disease Is Associated with Myeloid Hyperplasia and the Exhaustion of B-Cell Lineage.
Journal: International journal of molecular sciences
Published: June 08, 2021
Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia.
Journal: Antioxidants (Basel, Switzerland)
Published: December 20, 2019
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.
Journal: British journal of haematology
Published: February 19, 2019
SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 26, 2018
Last Updated: 09/26/2026